— Unanticipated late opposition by major Organovo stockholder results in termination of proposed merger agreement — — Tarveda continues advancement of current Pentarin® miniature drug conjugate clinical programs towards key clinical milestones — Watertown, MA – Tarveda Therapeutics, Inc. (“Tarveda”), a clinical stage biopharmaceutical company developing a new class of potent and selective precision oncology medicines, which it […]
WAYNE, N.J. — ProCulture®, the new workflow-minded product line for cell culture from Bel-Art and Wilmad-LabGlass brands, covers multiple steps of the cell culture process from isolation to harvesting. Products include an array of Shaker Flasks, Spinner Flasks with a unique impeller that increases aeration and eliminates dead spots, and an Orbital Shaker Platform that converts an […]
Polyplus-transfection® SA, the leading biotechnology company that supports the gene and cell therapy market by supplying innovative transfection solutions, today announces it will make available to the market a novel transfection reagent FectoVIR®-AAV in May 2020. The reagent has been specifically developed to improve AAV (adeno-associated virus) production in suspension cell culture system for large-scale […]
New arrayed B cell CRISPR knockout screening service strengthens support for development of therapeutics for diseases involving the immune system First in the market, this unique service complements the Company’s T cell screening service Horizon Discovery Group plc (LSE: HZD) (“Horizon”, “the Company” or “the Group”), a global leader in the application of gene editing […]
SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that Fluidigm® CyTOF® technology was used in a clinical study producing preliminary evidence that mesenchymal stem cell (MSC) therapy improves outcomes in patients with COVID-19 pneumonia, providing key information about […]
Back in September 2018, LGC acquired Lucigen Corporation. The ISO accredited site is based in Middleton, Wisconsin and employs just over 75 people. Lucigen specialises in enzymes, competent cells, and cloning systems to support applications in diagnostics, drug discovery, synthetic biology and gene editing, and now as a part of the Biosearch Technologies portfolio, is expanding […]
LEIDEN – BIOKÉ, a business unit of Cell Signaling Technology Europe, announced it has signed a distribution agreement with abc biopply, an innovative and dynamic biotech company, to distribute abc biopply’s 3D CoSeedis™ cell culture technology in the Netherlands, Belgium and Luxembourg (Benelux), effective immediately. “We cannot wait to bring the novel 3D CoSeedis™ cell […]
WINOOSKI VT, USA — BioTek Instruments today introduced a new kit that can help researchers quickly obtain high-quality cell count results by automating the often tedious and error-prone process of mammalian cell counting. The new Cell Count & Viability Starter Kit automates cell counting and viability measurements in a mammalian cell suspension. When used with BioTek’s Cytation™ Cell […]
Specially developed research-grade PepTivator® Peptide Pools for SARS-CoV-2 BERGISCH GLADBACH – Miltenyi Biotec today launches the SARS-CoV-2 PepTivator Peptide Pools, a new addition to its popular PepTivator Portfolio specifically developed to help researchers currently investigating COVID-19. Based on decades worth of experience in developing products for virus-specific T cell research, SARS-CoV-2 PepTivator Peptide Pools work by stimulating […]
SAN CARLOS, Calif. — CellFE, Inc., an innovative startup developing a microfluidics based device to deliver gene-editing molecules, today announced it has completed a $4.8 million Series Seed round of financing. Dynamk Capital and Cota Capital co-led the investment round with participation from Embark Ventures, Elm Ventures and McEwan Lane Family Trust. Dr. Gustavo Mahler, Venture Partner, Dynamk Capital […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
